Variable | Unadjusted PRR (95% CI) | p-value | Adjusted PRR (95% CI) | p-value |
---|---|---|---|---|
Model 1 | ||||
 Perceived risk | 0.98 (0.94–1.00) | 0.239 | 0.95 (0.90–1.00) | 0.055 |
 Perceived severity | 1.05 (0.99–1.10) | 0.085 | 1.04 (0.97–1.10) | 0.312 |
 Perceived benefits | 1.04 (0.99–1.10) | 0.125 | 0.97 (0.91–1.03) | 0.357 |
 Perceived barriers | 0.97 (0.95–0.99) | 0.004 | 1.00 (0.98–1.01) | 0.721 |
 Perceived self-efficacy | 1.18 (1.05–1.31) | 0.004 | 1.18 (1.05–1.23) | 0.005 |
Model 2 | ||||
 Perceived risk | 0.98 (0.97–1.03) | 0.239 | 0.97 (0.93–1.01) | 0.238 |
 Perceived severity | 1.07 (1.01–1.12) | 0.013 | 1.02 (0.96–1.08) | 0.577 |
 Perceived benefits | 1.10 (1.04–1.17) | 0.002 | 1.05 (0.97–1.12) | 0.237 |
 Perceived barriers | 0.97 (0.95–0.98) | < 0.001 | 0.99 (0.97–1.00) | 0.366 |
 Perceived self-efficacy | 1.38 (1.18–1.62) | < 0.001 | 1.40 (1.18–1.67) | < 0.001 |
Model 3 | ||||
 Perceived risk | 1.00 (0.96–1.03) | 0.986 | 0.92 (0.93–1.03) | 0.453 |
 Perceived severity | 1.05 (1.00–1.10) | 0.040 | 1.06 (0.98–1.14) | 0.150 |
 Perceived benefits | 1.08 (1.02–1.13) | 0.010 | 1.04 (0.96–1.13) | 0.304 |
 Perceived barriers | 0.98 (0.96–0.99) | 0.018 | 1.01 (0.98–1.02) | 0.677 |
 Perceived self-efficacy | 1.24 (1.09–1.40) | 0.001 | 1.20 (1.05–1.36) | 0.006 |